Back
to sessions
Sep 28
Poster Q & A
MODERATOR(S)
Neha Vapiwala, MD, FASTRO, FASCO, FACR - University of Pennsylvania
Presentations
-
04:00pm - 05:00pm ET
Low-Dose Hypofractionated Bridging Radiation (4Gy x 2 Fractions) Prior to CAR T-Cell Therapy for Relapsed/Refractory DLBCL
Speaker: Jonathan Baron, MD - University of Pennsylvania, Philadelphia -
04:00pm - 05:00pm ET
Dosimetric Outcomes and Clinical Toxicity from CT-Based Online Adaptive Hypofractionated Radiotherapy for Non-Operable Pancreatic Cancer
Speaker: John Peterson, MD - H. Lee Moffitt Cancer Center and Research Institute, Tampa -
04:00pm - 05:00pm ET
Expert Validation of Large Language Model Triage Predictions for Radiation Oncology Incident Learning System Forms
Speaker: Stephen Gardner, MS - Henry Ford Health System, Charter Township of Clinton -
04:00pm - 05:00pm ET
ctDNA Evaluation on a Phase I Trial of Pre-Operative Ablative Radiation for Early Stage Hormone Positive Breast Cancer
Speaker: Asal Rahimi, MD, MS - University of Texas Southwestern Medical Center at Dallas, Dallas -
04:00pm - 05:00pm ET
Quantifying Clinical Intuition in oART: Survey-Derived Development and Retrospective Validation of a Web-Based Adaptive Benefit Framework for Online Adaptive Radiotherapy
Speaker: Dennis Stanley, PhD - The University of Alabama at Birmingham, Birmingham -
04:00pm - 05:00pm ETSpeaker: Suraj Pai, PhD - Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston
-
04:00pm - 05:00pm ETSpeaker: Madeline Evans, BS - UAB Heersink School of Medicine, Birmingham
-
04:00pm - 05:00pm ET
Acute-Phase Semiquantitative Immune Cell Kinetics as Multi-Endpoint Prognostic Biomarkers for Survival Metrics in LA-NSCLC treated with Chemoradiotherapy
Speaker: Ying Xiao, PhD, FASTRO - University of Pennsylvania, Philadelphia -
04:00pm - 05:00pm ET
Identifying Risk Factors in the Re-Irradiation Using Risk Analysis - A Multi-Site Single-Institution Experience
Speaker: Yulun He, PhD - University of Washington, Seattle -
04:00pm - 05:00pm ETSpeaker: Sarah Han-Oh, PhD - Johns Hopkins University, Baltimore
-
04:00pm - 05:00pm ET
AARS1-Mediated Lactylation of XRCC5 Regulates the Stability of FOXO1 to Control Radioresistance In Nasopharyngeal Carcinoma
Speaker: Weisi Wang, MD - Nanjing Medical University, Nanjing -
04:00pm - 05:00pm ET
Impact of AI-Assisted Auto-Contouring Implementation on Workflow and Clinician Burden: A Paired Pre-Post Evaluation in a High-Volume Public Cancer Center
Speaker: Rohan Patel, MD, MPH - Medical College of Wisconsin, Milwaukee -
04:00pm - 05:00pm ET
Pediatric Upright Proton Therapy in a Tilting Chair: Anesthesia Integration, AV Immersion and Initial Clinical Experience
Speaker: Megan Clark, PhD, BS - Stanford University, Stanford -
04:00pm - 05:00pm ET
Risk-Controlled Selective Automation of Oncology Chart Review via Representational Stability Calibration
Speaker: Reza Khanmohammadi, MS - Michigan State University, East Lansing -
04:00pm - 05:00pm ET
Validating Dual Oxygenase 2 as a Modulator of Radiosensitivity and Expression of the Immune Checkpoint Program Death-Ligand 1 (PD-L1) in Esophageal Cancer
Speaker: Alexander Allen, MD - University of Maryland Medical Center, Baltimore -
04:00pm - 05:00pm ETSpeaker: James Matchynski, MD, PhD - University of Michigan, Ann Arbor
-
04:00pm - 05:00pm ET
Clinical Drivers of Recurrent Failure Modes in Radiation Oncology Identified through a Retrospective Mini-FMEA CQI Framework
Speaker: Vibha Chaswal, PhD - Miami Cancer Institute, Miami -
04:00pm - 05:00pm ETSpeaker: Olalekan Shehu, MS - Mayo Clinic, Rochester Radiation Oncology, Rochester
-
04:00pm - 05:00pm ET
Early HFRT With Pulsed LDRT and PD-1 Blockade Drives Systemic Antitumor Control via Coordinated Effector-Memory CD8? T-Cell Redistribution
Speaker: Hui-hui Hu, MS - Shanghai Chest Hospital , Shanghai Jiao Tong University School Of Medicine, Shanghai -
04:00pm - 05:00pm ET
Longitudinal Multi-omic Immune Profiling Reveals Persistent Systemic Dysregulation and Baseline Predictors of Recurrence After Breast Cancer Radiotherapy
Speaker: Zeliang Ma, MD - Mayo Clinic Rochester, Rochester -
04:00pm - 05:00pm ET
Same-Day Simulation-Free Radiotherapy Using Diagnostic CT: Feasibility and Dosimetric Validation in a Low-Resource Radiation Oncology Setting
Speaker: Baozhou Sun, PhD, MBA - Baylor College of Medicine, Houston -
04:00pm - 05:00pm ET
-
04:00pm - 05:00pm ET
Scalable Implementation of CBCT-Guided Adaptive Radiotherapy: Impact of RTT Integration, Advanced CBCT and AI Contouring
Speaker: Mu-Han Lin, PhD - UT Southwestern Medical Center, Dallas -
04:00pm - 05:00pm ET
Ultra-High Dose Rate Proton Irradiation Spares Peripheral Lymphocytes in Excess of Dose-Sparing Effect to Circulating Blood
Speaker: Joseph DeCunha, PhD - University of Washington/Fred Hutch Cancer Center, Seattle -
04:00pm - 05:00pm ETSpeaker: Harkiran Kooner, PhD - Johns Hopkins Hospital, Baltimore
-
04:00pm - 05:00pm ET
Root Cause Analysis of Unscheduled Replans across 19,249 Radiation Therapy Plans: A Five-Year Single-Institution Review
Speaker: Brian Anderson, PhD - UC San Diego Radiation Medicine and Applied Sciences, La Jolla -
04:00pm - 05:00pm ET
Prophylactic eFLASH Lung Radiotherapy Inhibits Growth of Lung Metastases and Prolongs Survival in a Murine Soft-Tissue Sarcoma Model
Speaker: Yomna Khamis, MD - University of Maryland, Baltimore -
04:00pm - 05:00pm ETSpeaker: Hoyeon Lee, PhD - University of Hong Kong, Hong Kong
-
04:00pm - 05:00pm ETSpeaker: Nimita Shinde, PhD - University of Texas Southwestern Medical Center at Dallas, Dallas
-
04:00pm - 05:00pm ETSpeaker: P.M. Quan Mai, BS - University of Texas Health Science Center at Houston, Houston
-
04:00pm - 05:00pm ET
Radiomics Feature Robustness of Photon-Counting CT and DECT in Chest Tumor Phantom: A Dual-Center, Multi-Device Study
Speaker: Yongbin Cui, PhD - Shandong Cancer Hospital and Institute, Jinan